Abstract

http://ssrn.com/abstract=273902
 


 



Genetic Susceptibility and Biomarkers in Toxic Injury Litigation


Gary E. Marchant, JD, PhD


Arizona State University - College of Law


Jurimetrics, Vol. 41, No. 1, Fall 2000

Abstract:     
The tort system generally treats plaintiffs as indistinguishable black boxes, entitled to compensation when a defendant's wrongful act or defective product causes some manifest disease or injury. This paradigm is likely to change dramatically with recent advances in genetic and related technologies. By peering inside the individual plaintiff to identify cellular and molecular markers that indicate both the status and etiology of pre-symptomatic disease processes, it will be possible to differentiate among individuals with respect to susceptibility and predispositions. This article surveys potential, and in some cases existing, uses of such biomarkers in toxic injury litigation and assesses the doctrinal, procedural, policy, and normative issues they present.

Accepted Paper Series





Not Available For Download

Date posted: June 19, 2001  

Suggested Citation

Marchant, JD, PhD, Gary E., Genetic Susceptibility and Biomarkers in Toxic Injury Litigation. Jurimetrics, Vol. 41, No. 1, Fall 2000. Available at SSRN: http://ssrn.com/abstract=273902

Contact Information

Gary E. Marchant, JD, PhD (Contact Author)
Arizona State University - College of Law ( email )
Box 877906
Tempe, AZ 85287-7906
United States
(480) 965-3246 (Phone)
(480) 965-2427 (Fax)
Feedback to SSRN


Paper statistics
Abstract Views: 471

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo3 in 0.329 seconds